FDA Grants Special Status for Kyverna's KYV-101 to Help Treat Severe Stiff-Person SyndromeJuly 27, 2024
FDA Grants Special Status for Kyverna's KYV-101 to Help Treat Severe Stiff-Person SyndromeJuly 27, 2024